Organometallics
Article
Y[2-(2,6-iPr2C6H3NCH)C4H3N]3 (1a). A toluene solution of 3
equiv of HL1 (399 mg, 1.567 mmol) and a suspension of freshly
prepared [YMe3]n (70 mg, 0.522 mmol) in toluene were cooled to
−35 °C and combined. The mixture cleared up after 1 h to give a
yellow solution. After the mixture was stirred for 16 h, the solvent was
removed in vacuo to yield the raw product as a pale yellow solid (441
mg, 99%). Two subsequent crystallizations from an n-hexane/toluene
mixture at −35 °C gave 119 mg (27%) of 1 as colorless crystals. NMR
data matched the literature values.11 IR (Nujol, cm−1): 1593 vs, 1424
vs, 1386 vs, 1342s, 1319 s, 1290 vs, 1259 vs, 1168 vs, 1035 vs, 979 vs,
894 vs, 878 s, 802 s, 786 m.
with [(C5Me5)YMe2]3 (40 mg, 0.157 mmol). Crystallization from an
n-hexane/toluene/benzene mixture at −35 °C gave 76 mg (78%) of
compound 4 as colorless crystals. IR (Nujol, cm−1): 1596 vs, 1301 vs,
1258 s, 1172 vs, 1095 m 1087 m, 1038 vs, 977 vs, 892 m, 882 s, 774 s
1
681 m, 607 m. H NMR (600 MHz, C6D6, 25 °C): δ 6.95 (t, 2H, p-
C6H3), 6.95 (br s, 2H, m-C6H3), 6.82 (br s, 2H, m-C6H3), 6.72 (d, 2H,
3-pyr), 6.57 (s, 2H, 5-pyr), 6.30 (dd, 2H, 4-pyr), 2.25 (br s, 6H, C6H3-
CH3), 1.90 (s, 15H, Cp-CH3), 1.49 (br s, 6H, C6H3-CH3) ppm.
13C{1H} NMR (151 MHz, C6D6, 25 °C): δ 163.5 (NCH) 148.7
(ipso-C6H3), 136.3 (p-C6H3), 132.8 (m-C6H3), 129.7 (m-C6H3), 125.1
(2-pyr), 123.0 (3-pyr), 119.5 (5-pyr), 113.3 (4-pyr), 19.3 (C6H3-CH3),
17.7 (C6H3-CH3), 11.4 (Cp-CH3) ppm. Anal. Calcd for C38H42N4Y
(643.683): C, 70.91; H, 6.58; N, 8.70. Found: C, 69.70; H, 6.32; N,
8.85.
Y[2-(2,6-Me2C6H3NCH)C4H3N]3 (1b). Proligand HL2 (446 mg,
2.25 mmol) was dissolved in 5 mL of toluene and added to a stirred
suspension of 100 mg of [YMe3]n (0.75 mmol) in 5 mL of toluene.
After it was stirred at ambient temperature for approximately 45 min,
the mixture cleared up but was stirred further overnight (16 h). The
solution was filtered, its volume reduced to about 3 mL, 1 mL of
hexane added, and the solution cooled to −35 °C. Crystallization of 1b
as small slightly yellow needles was initiated when the vial was taken
briefly out of the freezer. Within 2 h at −35 °C, 388 mg (76%) of 1b
crystallized and was isolated by decantation and washing with 1 mL of
toluene. DRIFT-IR (KBr, cm−1): 2968 w, 1595 m, 1566 vs, 1486 w,
1465 w, 1436 m, 1388 s, 1299 vs, 1260 m, 1172 s, 1033 vs, 978 m, 893
(C5Me5)2Y[2-(2,6-iPr2C6H3NCH)C4H3N] (5). A pentane solu-
tion of 1 equiv of HL1 (17.1 mg, 0.0672 mmol) was cooled to −35 °C
and added to a solution of (C5Me5)2YMe(THF) (30.0 mg, 0.0672
mmol) that was likewise precooled to −35 °C. The mixture cleared up
after 1 h to give a yellow solution. After the mixture was stirred for 16
h, the solvent was removed in vacuo to yield the raw product as a pale
yellow solid (39.5 mg, 96%). IR (KBr, cm−1): 2962 m, 2920 m, 2859
m, 1594 m, 1569 s, 1430 m, 1308 m, 1285 w, 1037 m, 873 w, 749 m,
1
699 w. H NMR (400 MHz, C6D6, 25 °C): δ 7.84 (s, 1H, NCH),
1
7.04 (dd, 1H, 3JHH = 3.4 Hz, 4JHH = 1.6 Hz, 3-pyr), 7.26−7.29 (m, 4H,
w, 883 m, 772 m, 750 s, 735 w, 679 w, 535 w. H NMR (400 MHz,
m-C6H3, p-C6H3, 5-pyr), 6.69 (dd, 1H, 3JHH = 3.4 Hz, 4JHH = 1.6 Hz, 4-
C6D6, 26 °C): δ 7.16 (m, 1H, 3-pyr), 6.85 (m, 1H, p-C6H3), 6.81 (m,
2H, m-C6H3), 6.80 (m, 1H, NCH), 6.58 (br s, 1H, 5-pyr), 6.24 (m,
1H, 4-pyr), 1.78 (s, 6H, C6H3-CH3) ppm. 13C {1H} NMR (100 MHz,
C6D6, 26 °C): δ 163.9 (NCH), 149.1 (i-C6H3), 139.8 (m, 3-pyr),
137.2 (2-pyr), 131.4 (o-C6H3), 128.7 (m-C6H3), 125.4 (p-C6H3),
123.2 (5-pyr), 113.7 (4-pyr), 18.5 (C6H3-CH3) ppm. Anal. Calcd for
C39H39N6Y (680.684): C, 68.82; H, 5.78; N, 12.35. Found: C, 68.59;
H, 5.50; N, 12.01.
3
pyr), 3.04 (sept, 2H, JHH = 6.7 Hz, CH(CH3)2), 1.97 (s, 30H,
3
Cp(CH3)), 1.35 (dd, 12H, JHH = 6.6 Hz, 4JHH = 3.1 Hz, CH(CH3)2)
ppm. 13C{1H} NMR (151 MHz, C6D6, 25 °C): δ 163.8 (NCH),
149.8 (ipso-C6H3), 140.1 (5-pyr), 129.3 (o-C6H3), 128.5 (m-C6H3),
125.6 (p-C6H3), 125.4 (2-pyr), 125.0 (3-pyr), 118.8 (Cp), 115.1 (4-
pyr), 28.8 (CH(CH3)2), 26.9 (CH(CH3)2), 25.7 (CH(CH3)2), 11.3
(Cp-CH3) ppm. Anal. Calcd for C37H51N2Y (612.720): C, 72.53; H,
8.39; N, 4.57. Found: C, 71.76; H, 8.17; N, 5.58.
{[2-(2,6-Me2C6H3NCH)C4H3N]Y[2-(2,6-Me2C6H3NC(H)(Me))-
C4H3N]}2 (2). In an experiment similar to the procedure described for
the synthesis of 1b, a toluene solution of 3 equiv of HL2 (311 mg,
1.567 mmol) and a suspension of freshly prepared [YMe3]n (70 mg,
0.522 mmol) in toluene were cooled to −35 °C and combined. After
45 min a clear yellow solution was observed. Stirring for another 16 h
and subsequent removal of the solvent in vacuo gave a mixture
(C5Me5)2Y[2-(2,6-Me2C6H3NCH)C4H3N] (6). Applying a pro-
cedure similar to the synthesis of 5, HL2 (13.3 mg, 0.0672 mmol) was
reacted with (C5Me5)2YMe(THF) (30.0 mg, 0.0672 mmol) in
toluene. Yield: 35.5 mg (94% yield). IR (KBr, cm−1): 2903 m, 2855
m, 1595 m, 1562 s, 1566 vs, 1468 m, 1388 m, 1306 m, 765 w, 749 w.
1H NMR (400 MHz, C6D6, 25 °C): δ 7.81 (s, 1H, NCH), 7.50 (m,
containing the free ligand HL2, homoleptic complex YL2 , and 2, as
3
3
1H, 5-pyr), 7.44 (m, 3H, m-C6H3, p-C6H3), 7.17 (dd, 1H, JHH = 3.6
Hz, 4JHH = 1 Hz, 3-pyr), 6.93 (dd, 1H, 3JHH = 3.6 Hz, 4JHH = 1 Hz, 4-
pyr), 2.16 (s, 6H, C6H3-CH3), 2.15 (s, 30H, Cp(CH3)) ppm. 13C{1H}
NMR (151 MHz, C6D6, 25 °C): δ 160.8 (NCH), 150.3 (ipso-
C6H3), 141.0 (5-pyr), 135.0 (o-C6H3), 130.0 (m-C6H3), 128.8 (p-
C6H3), 124.5 (2-pyr), 124.4 (3-pyr), 115.0 (4-pyr), 118.2 (Cp), 21.2
(C6H3-CH3), 11.2 (Cp-CH3) ppm. Anal. Calcd for C33H43N2Y·C4H8O
(628.719): C, 70.68; H, 8.18; N, 4.46. Found: C, 70.31; H, 8.64; N,
4.63.
{(AlMe4)La[2-(2,6-iPr2C6H3NC(H)(Me))C4H3N]}2 (7). An n-hex-
ane solution of La(AlMe4)3 (100 mg, 0.250 mmol) was combined with
a suspension of an equimolar amount of KL1 (73.07 mg, 0.250 mmol)
in n-hexane. The suspension turned yellow after 45 min, and the solid
part was evenly distributed. After the mixture was stirred for 16 h, the
white solid part was separated by centrifugation. The yellow solution
was filtered and the solvent removed in vacuo to yield a slightly yellow
oily solid. Crystallization from an n-hexane/toluene/benzene mixture
at −35 °C gave 20.9 mg (17%) of compound 7 as colorless crystals. IR
(KBr, cm−1): 2957 s, 2924 s, 2880 s, 1458 m, 1437 m, 1246 s, 1187 s,
912 w, 861 m, 798 m, 695 vs, 667 s. Anal. Calcd for C44H72Al2N4La2
(988.866): C, 53.44; H, 7.34; N, 5.67. Found: C, 53.04; H, 7.48; N,
4.89.
(AlMe4)2Y[2-(2,6-Me2C6H3NCH)C4H3N] (8). In a procedure
similar to the synthesis of 7, KL2 (67.5 mg, 0.286 mmol) was reacted
with Y(AlMe4)3 (100 mg, 0.286 mmol). Crystallization from an n-
hexane/toluene/benzene mixture at −35 °C gave 53.5 mg (41%) of 8
as colorless crystals. IR (KBr, cm−1): 2915 s, 2880 m, 1587 w, 1454 m,
1302 w, 1250 m, 1189 m, 793 m, 768 m, 693 s, 573 m. 1H NMR (600
MHz, C6D6, 25 °C): δ 7.16 (s, 1H, 5-pyr), 6.86 (s, 2H, m-C6H3), 6.83
(m, 1H, p-C6H3), 6.69 (d, 1H, 3-pyr), 6.33 (dd, 1H, 4-pyr), 1.93 (s,
6H, C6H3-CH3), −0.17 (d, 24H, Al-CH3) ppm. 13C{1H} NMR (151
indicated by NMR spectroscopy. Fractionate crystallization from a
toluene/hexane mixture at −35 °C gave complex 2 in form of several
small colorless blocks. Collecting these crystals for X-ray structure
analysis with a pipet initiated the crystallization of the main product 1b
in large amounts.
(C5Me5)Y[2-(2,6-iPr2C6H3NCH)C4H3N]2 (3). A toluene solution
of 2 equiv of HL1 (80.1 mg, 0.315 mmol) was cooled to −35 °C and
added to a suspension of freshly prepared [(C5Me5)YMe2]3 (40 mg,
0.157 mmol) in toluene likewise precooled to −35 °C. The mixture
cleared up totally after 45 min to give a yellow solution. After the
mixture was stirred for 5 h, the solvent was removed in vacuo to yield
the raw product as a pale yellow solid. Crystallization from an n-
hexane/toluene/benzene mixture at −35 °C gave 71 mg (62%) of
compound 3 as colorless crystals. IR (KBr, cm−1): 2962 s, 2925 s, 2864
s, 1592 s, 1566 vs, 1496 m, 1454 s, 1283 s, 1039 s, 749 s, 690 s, 681 s.
1H NMR (600 MHz, C6D6, 25 °C): δ 7.82 (s, 2H, NCH), 7.03 (t,
2H, p-C6H3), 7.02 (br s, 2H, m-C6H3), 6.95 (br s, 2H, m-C6H3), 6.70
(d, 2H, 3-pyr), 6.59 (s, 2H, 5-pyr), 6.40 (m, 2H, 4-pyr), 3.44 (h, 2H,
CH(CH3)2), 2.75 (h, 2H, CH(CH3)2), 1.90 (s, 15H, Cp-CH3), 1.44
(d, 6H, CH(CH3)2), 1.14 (d, 6H, CH(CH3)2), 0.92 (d, 6H,
CH(CH3)2), 0.69 (d, 6H, CH(CH3)2) ppm. 13C{1H} NMR (151
MHz, C6D6, 25 °C): δ 163.5 (NCH), 149.4 (ipso-C6H3), 139.5 (5-
pyr), 129.1 (o-C6H3), 128.1 (o-C6H3), 126.2 (m-C6H3), 125.6 (m-
C6H3), 123.2 (3-pyr), 123.4 (2-pyr), 119.8 (Cp), 113.2 (4-pyr), 30.2
(CH(CH3)2), 28.0 (CH(CH3)2), 27.2 (CH(CH3)2), 26.9 (CH-
(CH3)2), 23.2 (CH(CH3)2), 20.3 (CH(CH3)2), 11.5 (Cp-CH3)
ppm. Anal. Calcd for C44H57N4Y (730.868): C, 72.31; H, 7.86; N,
7.67. Found: C, 72.77; H, 7.86; N, 7.32.
(C5Me5)Y[2-(2,6-Me2C6H3NCH)C4H3N]2 (4). By a procedure
similar to the synthesis of 3, HL2 (62.5 mg, 0.315 mmol) was reacted
1205
dx.doi.org/10.1021/om301002n | Organometallics 2013, 32, 1199−1208